Altheia Science is a pioneering start-up founded by two world renowned Italian scientists, Prof. Alessandra Biffi, MD and Prof. Paolo Fiorina, MD, PhD, together with AurorA-TT. Altheia Science’s pipeline exploits pioneering therapeutic tools for autoimmune diseases and cancer.
biotechnology, gene therapy, advanced therapy
Between €10 million-€25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Altheia Science? We’re happy to assist you with our Startup Sourcing service.